An analysis of the Spanish El Álamo IV registry shows that age, stage, histological grade and tumour subtype are linked to distinct relapse patterns....
An updated review covers the evidence on the HER2DX genomic test to individualise treatment intensity in early-stage HER2-positive breast cancer....
A translational analysis of the GEICAM PEARL trial shows that blood thymidine kinase is a prognostic marker and that its early changes provide treatment-specific information....